These drugs work by improving the function of the CFTR protein, which enhances lung function and reduces infection frequency. Drugs like Ivacaftor (Kalydeco), Lumacaftor/Ivacaftor (Orkambi), and Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) have significantly improved patients' lives,